Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Small lymphocytic lymphoma

Precursor B-cell neoplasm Precursor B-lymphoblastic leukemia/lymphoma Mature (peripheral) B-cell neoplasms B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma... [Pg.1374]

Hainsworth, J.D., Litchy, S., Barton, J.H., Houston, G.A., Hermann, R.C., Bradof, J.E., and Greco, RA., Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma a phase II trial of the Minnie Pearl Gancer Research Network, /. Clin. Oncol., 21,1746-2751, 2003. [Pg.584]

B cell neoplasms based on morphology, immunophenotype, and genotype often, but not always, correspond to stages of B cell development. However, some B cell lymphomas either do not clearly correspond to a specific developmental stage (i.e., appear to be of variable origin such as chronic lymphocytic leukemia/small lymphocytic lymphoma) or do not appear to be related to any known stage of normal development (i.e., hairy cell leukemia) (H10). [Pg.309]

CLL/SLL, Chronic lymphocytic leukemia/small lymphocytic lymphoma MCL, mantle cell lymphoma FL, follicular lymphoma MZL/MALT, marginal zone lymphoma/mucosa-associated lymphoid tisuse lymphoma SMZL, splenic marginal zone lymphoma HCL, hairy cell leukemia DLCL, diffuse large-cell lymphoma PCM, plasma cell myeloma BCL-1, cyclin D1 FDC MW, Follicular dendritic cell meshworks CK, cytokeratin LELs, lymphoepitheilal lesions. [Pg.311]

D26. Dunphy, C. H., Wheaton, S. E., and Perkins, S. L., CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic tranformations of mantle cell lymphoma. Mod. Pathol. 10, 818-822 (1997). [Pg.335]

K8. Kilo, M. N., and Dorfman, D. M., The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma. Am. J. Clin. Pathol. 105, 451—457 (1996). [Pg.340]

K30. Kroft, S. H., Dawson, D. B., and McKenna, R. W., Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases. Am. J. Clin. Pathol. 115, 385-395 (2001). [Pg.341]

Perkins JG, Flynn JM, Howard RS, Byrd JC. Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma implications for clinical trials in this patient population. Cancer 2002 94(7) 2033-9. [Pg.1392]

Ramnani D, Lindberg G, Gokaslan ST, et al. Signet-ring cell variant of small lymphocytic lymphoma with a prominent sinusoidal pattern. Ann Diagn Pathol. 1999 3 220-226. [Pg.133]

B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA... [Pg.169]

Kumar S, Green GA, Teruya-Feldstein J, et al. Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocytic lymphoma and mantle cell lymphoma. Mod Pathol. 1996 9(9) 925-929. [Pg.184]

Tworek JA, Singleton TP, Schnitzer B, et al. Flow cytometric and immunohistochemical analysis of small lymphocytic lymphoma, mantle cell lymphoma, and plasmacytoid small lymphocytic lymphoma. Am J Clin Pathol. 1998 110(5) 582-589. [Pg.185]

S Small lymphocytic lymphoma (WDLL) f Drugs (penicillin)... [Pg.191]

Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL)... [Pg.198]

Shao H, Xi L, Raffeld M, Feldman AL, Kettoling RP, Knudson R, Rodriguez-Canales J, Hanson J, Pittaluga S, Jaffe ES. Clonally related histiocytic/dendtitic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma a study of seven cases. Mod Pathol. 2011 24 1421-32. [Pg.763]

In a phase lb-2 multicenter study to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of ibrutinib in patients with relapsed or refractory CLL or small lymphocytic lymphoma, a total of 85 patients received ibrutinib orally once a day (51 received 420 mg and 34 received 840 mg) The overall response rate was 71% in both groups. At 26 months, the estimated progression-free survival rate was 75% and the rate of overall survival was 83%. [Pg.161]

Levesque and colleagues reported expression of NOSl in CLL cells and that NOSl inhibitors of NOSl induce apoptosis and death in freshly isolated CLL cells in vitro (Levesque et al. 2008). This is discussed in more detail below. Some non-Hodgkin s, small lymphocytic lymphoma, and multiple myeloma cells also express NOSl (Mendes et al. 2001). [Pg.150]

Tragara Pharmaceuticals, Inc. Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, http //www.clinicaltrials.gov/ct2/show/NCT01699152 [accessed Feh. 2014]. [Pg.223]

See other pages where Small lymphocytic lymphoma is mentioned: [Pg.1374]    [Pg.312]    [Pg.411]    [Pg.1459]    [Pg.2450]    [Pg.165]    [Pg.174]    [Pg.174]    [Pg.392]    [Pg.444]    [Pg.198]    [Pg.202]    [Pg.202]    [Pg.459]    [Pg.338]    [Pg.254]    [Pg.539]    [Pg.207]   
See also in sourсe #XX -- [ Pg.2450 ]

See also in sourсe #XX -- [ Pg.254 ]



SEARCH



Lymphoma

Lymphoma lymphocytic

Lymphomas lymphocytic lymphoma

Lymphomas lymphoma

© 2024 chempedia.info